Details for New Drug Application (NDA): 017493
NDA 017493 describes TRAVASOL 8.5% W/O ELECTROLYTES, which is a drug marketed by Baxter Hlthcare and is included in one NDA. Additional details are available on the TRAVASOL 8.5% W/O ELECTROLYTES profile page.
The generic ingredient in TRAVASOL 8.5% W/O ELECTROLYTES is amino acids. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.
The generic ingredient in TRAVASOL 8.5% W/O ELECTROLYTES is amino acids. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.
Summary for 017493
| Tradename: | TRAVASOL 8.5% W/O ELECTROLYTES |
| Applicant: | Baxter Hlthcare |
| Ingredient: | amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
